What is the recommended initial shock dose in joules for ventricular tachycardia using a biphasic defibrillator?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Shock Energy for Ventricular Tachycardia

For ventricular tachycardia with a pulse, use synchronized cardioversion starting at 100 joules (biphasic or monophasic); for pulseless ventricular tachycardia, use unsynchronized defibrillation at 200 joules or the manufacturer's recommended dose for biphasic devices. 1, 2

Critical First Step: Assess for Pulse

The presence or absence of a pulse fundamentally changes your approach:

  • Pulseless VT = Cardiac Arrest: Treat identically to ventricular fibrillation with immediate unsynchronized high-energy shocks (defibrillation) 1, 2
  • VT with Pulse = Perfusing Rhythm: Use synchronized cardioversion at lower initial energy 1, 2

Never use synchronized cardioversion for pulseless VT—this delays treatment of a cardiac arrest rhythm and worsens mortality. 1, 3

For Pulseless Ventricular Tachycardia (No Pulse)

Initial Energy Dose

  • Biphasic defibrillators: Use manufacturer's recommended dose (typically 120-200 J); if unknown, use maximum dose 4
  • Monophasic defibrillators: Start at 200 J 5
  • Biphasic shocks achieve 85-98% effectiveness at ≤200 J 4

Subsequent Shocks

  • Follow manufacturer's instructions for fixed versus escalating energy 4
  • If using escalating energy protocol, higher energy for second and subsequent shocks may be considered 4
  • Deliver shocks immediately without delay—do not synchronize 1

Key Technical Points

  • Use unsynchronized shocks only—the device cannot reliably detect QRS complexes in VF/pulseless VT 1
  • Deliver shock immediately after rhythm check without waiting for synchronization 1
  • Continue high-quality CPR between shocks 4

For Ventricular Tachycardia with Pulse

Monomorphic VT (Regular, Wide Complex)

  • Initial energy: 100 joules synchronized (applies to both biphasic and monophasic waveforms) 1, 2
  • If first shock fails, escalate energy in stepwise fashion 1, 2
  • Must use synchronized mode—shock delivered at peak of QRS complex, never on T wave 2

Polymorphic VT (Irregular, Wide Complex)

  • Treat as ventricular fibrillation with unsynchronized high-energy shocks 1, 3
  • Never attempt synchronized cardioversion—synchronization is not possible with irregular rhythm 1, 3
  • Use ≥200 J (or manufacturer's recommended biphasic dose) 1

Critical Safety Considerations

Before Delivering Shock

  • Hemodynamically unstable patients: Cardiovert immediately without delay for sedation 3, 2
  • Hemodynamically stable patients: Provide adequate sedation or anesthesia before synchronized cardioversion 3, 2
  • Establish IV access if time permits, but do not delay shock in extremely unstable patients 3

Synchronization Verification

  • Turn on synchronization function and verify the device is detecting QRS complexes appropriately before proceeding 3
  • Ensure visible artifact indicates shock timing in relation to QRS 4
  • Common pitfall: Forgetting to reactivate synchronization mode after each shock—most devices default back to unsynchronized mode 2

Equipment Readiness

  • Have defibrillation equipment immediately available when treating unstable VT, as patients may deteriorate to pulseless VT or VF at any moment 1, 3
  • Be prepared for post-cardioversion arrhythmias including atrial or ventricular premature complexes that may trigger recurrent episodes 3

Electrode Positioning

  • Anteroposterior configuration is preferred over anterolateral (87% vs 76% success rate, requires less energy) 2
  • For patients with implanted cardiac devices, position electrodes as far as possible from pulse generator, preferably anteroposterior 2

Energy Escalation Protocol

If initial shock fails:

  1. Increase energy in stepwise fashion for subsequent attempts 1, 2
  2. Allow at least 1 minute between consecutive shocks to avoid myocardial damage 2
  3. Consider antiarrhythmic medication (amiodarone) to prevent recurrence 3

Special Populations

Pediatric Patients

  • VF or pulseless VT: 2 J/kg first shock, 4 J/kg second shock, 4-10 J/kg subsequent shocks 1
  • These are unsynchronized defibrillation doses, not cardioversion doses 1

Common Pitfalls to Avoid

  1. Never synchronize for pulseless VT—this is cardiac arrest requiring immediate unsynchronized defibrillation 1, 3
  2. Never synchronize for polymorphic VT—even with a pulse, treat as VF 1, 3
  3. Never use synchronized cardioversion for VF—device may not sense QRS and deliver no shock 1, 3
  4. Never delay cardioversion in unstable patients to attempt pharmacological conversion 3
  5. Never use calcium channel blockers in VT—they worsen hemodynamic status 3

References

Guideline

Shock Synchronization in Ventricular Fibrillation and Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Synchronized Cardioversion Energy for Ventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Synchronized Cardioversion for Arrhythmias

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.